Cargando…
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
The transmembrane zink-metalloendopeptidase neprilysin (NEP) is implicated in cardiovascular disease but also tumor biology. The aim of the study was to investigate the relationship of circulating NEP (cNEP) levels with established cardiovascular biomarkers and its effect on overall survival in an u...
Autores principales: | Pavo, Noemi, Arfsten, Henrike, Cho, Anna, Goliasch, Georg, Bartko, Philipp E., Wurm, Raphael, Freitag, Claudia, Gisslinger, Heinz, Kornek, Gabriela, Strunk, Guido, Raderer, Markus, Zielinski, Christoph, Hülsmann, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385211/ https://www.ncbi.nlm.nih.gov/pubmed/30796257 http://dx.doi.org/10.1038/s41598-019-38867-2 |
Ejemplares similares
-
GDF‐15 in solid vs non‐solid treatment‐naïve malignancies
por: Arfsten, Henrike, et al.
Publicado: (2019) -
Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
por: Prausmüller, Suriya, et al.
Publicado: (2020) -
Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020) -
The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020) -
Relevance of Neutrophil Neprilysin in Heart Failure
por: Prausmüller, Suriya, et al.
Publicado: (2021)